Bayer Schering CEO says price pressure up - paper
FRANKFURT, June 14 (Reuters) - The Chief Executive of Bayer BAYG.DE's pharmaceutical unit, Bayer Schering Pharma, said price pressures in the industry are intensifying due to the economic crisis, a German daily newspaper reported.
"Price pressure in the pharmaceutical branch is increasing," Andreas Fibig said in a pre-release of an article in Tagesspiegel's Monday edition.
He said the effects of the worldwide economic slump are being felt mainly in markets where patients have to pay for their own medications.
He forecast the global pharmaceutical market would grow only by 2-3 percent this year.
Bayer Schering wanted to grow faster than the market and still expected double-digit growth in China.
Bayer Schering would restructure its research and development activities, with productivity growth to be generated mainly with help of external partners, he said. (editing by John Stonestreet)
© Thomson Reuters 2009 All rights reserved
India Investment Summit 2009
Top executives and bankers discuss their own plans and the broader opportunities and challenges for India. Full Coverage
GLOBAL RECOVERY
Global economy in holding pattern - IMF
The global economy is in a holding pattern and vulnerable to more upheaval, the head of the IMF said, adding a lasting recovery will depend on policymakers taking the proper steps in the coming months. Full Article
India
US
UK
